nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—pancreatic cancer	0.677	1	CbGaD
Nepafenac—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.238	1	CrCrCtD
Nepafenac—Ulcerative keratitis—Erlotinib—pancreatic cancer	0.00563	0.0722	CcSEcCtD
Nepafenac—Scab—Fluorouracil—pancreatic cancer	0.00306	0.0392	CcSEcCtD
Nepafenac—Impaired healing—Sunitinib—pancreatic cancer	0.00285	0.0365	CcSEcCtD
Nepafenac—Visual acuity reduced—Tamoxifen—pancreatic cancer	0.00242	0.031	CcSEcCtD
Nepafenac—Keratitis—Erlotinib—pancreatic cancer	0.00219	0.0281	CcSEcCtD
Nepafenac—Lacrimation—Irinotecan—pancreatic cancer	0.00173	0.0221	CcSEcCtD
Nepafenac—Lacrimation—Fluorouracil—pancreatic cancer	0.00165	0.0212	CcSEcCtD
Nepafenac—Blepharitis—Fluorouracil—pancreatic cancer	0.00158	0.0202	CcSEcCtD
Nepafenac—Cataract—Tamoxifen—pancreatic cancer	0.00151	0.0194	CcSEcCtD
Nepafenac—Lacrimation increased—Sunitinib—pancreatic cancer	0.00134	0.0171	CcSEcCtD
Nepafenac—Dermatitis atopic—Gemcitabine—pancreatic cancer	0.00134	0.0171	CcSEcCtD
Nepafenac—Dry eye—Erlotinib—pancreatic cancer	0.00131	0.0168	CcSEcCtD
Nepafenac—Blood pressure increased—Sunitinib—pancreatic cancer	0.00123	0.0158	CcSEcCtD
Nepafenac—Lacrimation—Docetaxel—pancreatic cancer	0.00119	0.0153	CcSEcCtD
Nepafenac—Eye irritation—Fluorouracil—pancreatic cancer	0.00114	0.0146	CcSEcCtD
Nepafenac—Lacrimation increased—Irinotecan—pancreatic cancer	0.0011	0.0141	CcSEcCtD
Nepafenac—Arthritis—Tamoxifen—pancreatic cancer	0.00107	0.0138	CcSEcCtD
Nepafenac—Lacrimation increased—Fluorouracil—pancreatic cancer	0.00105	0.0135	CcSEcCtD
Nepafenac—Dermatitis atopic—Docetaxel—pancreatic cancer	0.000948	0.0121	CcSEcCtD
Nepafenac—Photophobia—Fluorouracil—pancreatic cancer	0.000913	0.0117	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—pancreatic cancer	0.00087	0.137	CrCbGaD
Nepafenac—Eye irritation—Docetaxel—pancreatic cancer	0.000822	0.0105	CcSEcCtD
Nepafenac—Lacrimation—Epirubicin—pancreatic cancer	0.000805	0.0103	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—pancreatic cancer	0.000771	0.121	CrCbGaD
Nepafenac—Lacrimation increased—Docetaxel—pancreatic cancer	0.000761	0.00975	CcSEcCtD
Nepafenac—Sinusitis—Tamoxifen—pancreatic cancer	0.000755	0.00967	CcSEcCtD
Nepafenac—Lacrimation—Doxorubicin—pancreatic cancer	0.000745	0.00954	CcSEcCtD
Nepafenac—Keratitis—Epirubicin—pancreatic cancer	0.00073	0.00935	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—pancreatic cancer	0.000715	0.112	CrCbGaD
Nepafenac—Blood pressure increased—Docetaxel—pancreatic cancer	0.000702	0.00899	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—pancreatic cancer	0.000686	0.108	CrCbGaD
Nepafenac—Keratitis—Doxorubicin—pancreatic cancer	0.000675	0.00865	CcSEcCtD
Nepafenac—Eye disorder—Erlotinib—pancreatic cancer	0.000668	0.00856	CcSEcCtD
Nepafenac—Dermatitis atopic—Epirubicin—pancreatic cancer	0.000639	0.00819	CcSEcCtD
Nepafenac—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.000592	0.00758	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—pancreatic cancer	0.000583	0.0915	CrCbGaD
Nepafenac—Eye disorder—Sunitinib—pancreatic cancer	0.000578	0.00741	CcSEcCtD
Nepafenac—Angiopathy—Sunitinib—pancreatic cancer	0.000561	0.00719	CcSEcCtD
Nepafenac—Immune system disorder—Sunitinib—pancreatic cancer	0.000559	0.00716	CcSEcCtD
Nepafenac—Hypertension—Tamoxifen—pancreatic cancer	0.000543	0.00696	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—pancreatic cancer	0.000542	0.0851	CrCbGaD
Nepafenac—Fenbufen—PTGS2—pancreatic cancer	0.00053	0.0833	CrCbGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000526	0.00674	CcSEcCtD
Nepafenac—Dry mouth—Tamoxifen—pancreatic cancer	0.000524	0.00671	CcSEcCtD
Nepafenac—Lacrimation increased—Epirubicin—pancreatic cancer	0.000514	0.00658	CcSEcCtD
Nepafenac—Sinusitis—Fluorouracil—pancreatic cancer	0.00051	0.00654	CcSEcCtD
Nepafenac—Nervous system disorder—Erlotinib—pancreatic cancer	0.000498	0.00638	CcSEcCtD
Nepafenac—Skin disorder—Erlotinib—pancreatic cancer	0.000493	0.00632	CcSEcCtD
Nepafenac—Lacrimation increased—Doxorubicin—pancreatic cancer	0.000475	0.00609	CcSEcCtD
Nepafenac—Hypertension—Sunitinib—pancreatic cancer	0.000465	0.00596	CcSEcCtD
Nepafenac—Angiopathy—Irinotecan—pancreatic cancer	0.000462	0.00592	CcSEcCtD
Nepafenac—Salsalate—PTGS2—pancreatic cancer	0.000461	0.0723	CrCbGaD
Nepafenac—Immune system disorder—Irinotecan—pancreatic cancer	0.00046	0.0059	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000455	0.00584	CcSEcCtD
Nepafenac—Angiopathy—Gemcitabine—pancreatic cancer	0.00045	0.00577	CcSEcCtD
Nepafenac—Dry mouth—Sunitinib—pancreatic cancer	0.000449	0.00575	CcSEcCtD
Nepafenac—Immune system disorder—Gemcitabine—pancreatic cancer	0.000448	0.00575	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000443	0.00568	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000438	0.00562	CcSEcCtD
Nepafenac—Dry eye—Epirubicin—pancreatic cancer	0.000437	0.0056	CcSEcCtD
Nepafenac—Nervous system disorder—Sunitinib—pancreatic cancer	0.000431	0.00552	CcSEcCtD
Nepafenac—Skin disorder—Sunitinib—pancreatic cancer	0.000427	0.00547	CcSEcCtD
Nepafenac—Dry eye—Doxorubicin—pancreatic cancer	0.000404	0.00518	CcSEcCtD
Nepafenac—Vision blurred—Fluorouracil—pancreatic cancer	0.000401	0.00513	CcSEcCtD
Nepafenac—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000395	0.00506	CcSEcCtD
Nepafenac—Hypertension—Irinotecan—pancreatic cancer	0.000383	0.00491	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—pancreatic cancer	0.000381	0.0598	CrCbGaD
Nepafenac—Eye pain—Epirubicin—pancreatic cancer	0.000381	0.00488	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00038	0.00486	CcSEcCtD
Nepafenac—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000378	0.00485	CcSEcCtD
Nepafenac—Hypertension—Gemcitabine—pancreatic cancer	0.000373	0.00478	CcSEcCtD
Nepafenac—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000365	0.00468	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000365	0.00468	CcSEcCtD
Nepafenac—Pruritus—Tamoxifen—pancreatic cancer	0.000363	0.00465	CcSEcCtD
Nepafenac—Pruritus—Erlotinib—pancreatic cancer	0.000359	0.0046	CcSEcCtD
Nepafenac—Nervous system disorder—Irinotecan—pancreatic cancer	0.000355	0.00455	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—pancreatic cancer	0.000353	0.0554	CrCbGaD
Nepafenac—Eye pain—Doxorubicin—pancreatic cancer	0.000352	0.00451	CcSEcCtD
Nepafenac—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000346	0.00443	CcSEcCtD
Nepafenac—Skin disorder—Gemcitabine—pancreatic cancer	0.000343	0.00439	CcSEcCtD
Nepafenac—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00034	0.00436	CcSEcCtD
Nepafenac—Dizziness—Tamoxifen—pancreatic cancer	0.000339	0.00435	CcSEcCtD
Nepafenac—Dizziness—Erlotinib—pancreatic cancer	0.000336	0.0043	CcSEcCtD
Nepafenac—Eye disorder—Docetaxel—pancreatic cancer	0.000329	0.00422	CcSEcCtD
Nepafenac—Vomiting—Tamoxifen—pancreatic cancer	0.000326	0.00418	CcSEcCtD
Nepafenac—Hypersensitivity—Sunitinib—pancreatic cancer	0.000324	0.00415	CcSEcCtD
Nepafenac—Vomiting—Erlotinib—pancreatic cancer	0.000323	0.00414	CcSEcCtD
Nepafenac—Headache—Tamoxifen—pancreatic cancer	0.000322	0.00412	CcSEcCtD
Nepafenac—Angiopathy—Docetaxel—pancreatic cancer	0.00032	0.0041	CcSEcCtD
Nepafenac—Immune system disorder—Docetaxel—pancreatic cancer	0.000318	0.00408	CcSEcCtD
Nepafenac—Headache—Erlotinib—pancreatic cancer	0.000318	0.00408	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000313	0.00401	CcSEcCtD
Nepafenac—Pruritus—Sunitinib—pancreatic cancer	0.000311	0.00398	CcSEcCtD
Nepafenac—Nausea—Tamoxifen—pancreatic cancer	0.000305	0.00391	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000305	0.0039	CcSEcCtD
Nepafenac—Nausea—Erlotinib—pancreatic cancer	0.000302	0.00386	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000299	0.00384	CcSEcCtD
Nepafenac—Dizziness—Sunitinib—pancreatic cancer	0.000291	0.00372	CcSEcCtD
Nepafenac—Vomiting—Sunitinib—pancreatic cancer	0.00028	0.00358	CcSEcCtD
Nepafenac—Headache—Sunitinib—pancreatic cancer	0.000275	0.00353	CcSEcCtD
Nepafenac—Hypersensitivity—Irinotecan—pancreatic cancer	0.000267	0.00342	CcSEcCtD
Nepafenac—Hypertension—Docetaxel—pancreatic cancer	0.000265	0.00339	CcSEcCtD
Nepafenac—Nausea—Sunitinib—pancreatic cancer	0.000261	0.00335	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000259	0.00332	CcSEcCtD
Nepafenac—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000256	0.00327	CcSEcCtD
Nepafenac—Dry mouth—Docetaxel—pancreatic cancer	0.000255	0.00327	CcSEcCtD
Nepafenac—Diclofenac—PTGS2—pancreatic cancer	0.000254	0.0398	CrCbGaD
Nepafenac—Pruritus—Gemcitabine—pancreatic cancer	0.00025	0.0032	CcSEcCtD
Nepafenac—Sinusitis—Epirubicin—pancreatic cancer	0.000248	0.00318	CcSEcCtD
Nepafenac—Nervous system disorder—Docetaxel—pancreatic cancer	0.000245	0.00315	CcSEcCtD
Nepafenac—Pruritus—Fluorouracil—pancreatic cancer	0.000245	0.00314	CcSEcCtD
Nepafenac—Skin disorder—Docetaxel—pancreatic cancer	0.000243	0.00312	CcSEcCtD
Nepafenac—Dizziness—Irinotecan—pancreatic cancer	0.000239	0.00307	CcSEcCtD
Nepafenac—Vomiting—Irinotecan—pancreatic cancer	0.00023	0.00295	CcSEcCtD
Nepafenac—Sinusitis—Doxorubicin—pancreatic cancer	0.00023	0.00294	CcSEcCtD
Nepafenac—Dizziness—Fluorouracil—pancreatic cancer	0.000229	0.00294	CcSEcCtD
Nepafenac—Headache—Irinotecan—pancreatic cancer	0.000227	0.00291	CcSEcCtD
Nepafenac—Ketoprofen—PTGS2—pancreatic cancer	0.000225	0.0353	CrCbGaD
Nepafenac—Vomiting—Gemcitabine—pancreatic cancer	0.000224	0.00287	CcSEcCtD
Nepafenac—Eye disorder—Epirubicin—pancreatic cancer	0.000222	0.00285	CcSEcCtD
Nepafenac—Headache—Gemcitabine—pancreatic cancer	0.000221	0.00283	CcSEcCtD
Nepafenac—Vomiting—Fluorouracil—pancreatic cancer	0.000221	0.00283	CcSEcCtD
Nepafenac—Headache—Fluorouracil—pancreatic cancer	0.000217	0.00278	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000216	0.00277	CcSEcCtD
Nepafenac—Angiopathy—Epirubicin—pancreatic cancer	0.000216	0.00276	CcSEcCtD
Nepafenac—Nausea—Irinotecan—pancreatic cancer	0.000215	0.00276	CcSEcCtD
Nepafenac—Immune system disorder—Epirubicin—pancreatic cancer	0.000215	0.00275	CcSEcCtD
Nepafenac—Nausea—Gemcitabine—pancreatic cancer	0.00021	0.00268	CcSEcCtD
Nepafenac—Nausea—Fluorouracil—pancreatic cancer	0.000206	0.00264	CcSEcCtD
Nepafenac—Eye disorder—Doxorubicin—pancreatic cancer	0.000206	0.00263	CcSEcCtD
Nepafenac—Angiopathy—Doxorubicin—pancreatic cancer	0.0002	0.00256	CcSEcCtD
Nepafenac—Immune system disorder—Doxorubicin—pancreatic cancer	0.000199	0.00254	CcSEcCtD
Nepafenac—Vision blurred—Epirubicin—pancreatic cancer	0.000195	0.0025	CcSEcCtD
Nepafenac—Hypersensitivity—Docetaxel—pancreatic cancer	0.000184	0.00236	CcSEcCtD
Nepafenac—Vision blurred—Doxorubicin—pancreatic cancer	0.00018	0.00231	CcSEcCtD
Nepafenac—Hypertension—Epirubicin—pancreatic cancer	0.000179	0.00229	CcSEcCtD
Nepafenac—Pruritus—Docetaxel—pancreatic cancer	0.000177	0.00227	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000175	0.00224	CcSEcCtD
Nepafenac—Dry mouth—Epirubicin—pancreatic cancer	0.000172	0.00221	CcSEcCtD
Nepafenac—Nervous system disorder—Epirubicin—pancreatic cancer	0.000166	0.00212	CcSEcCtD
Nepafenac—Dizziness—Docetaxel—pancreatic cancer	0.000166	0.00212	CcSEcCtD
Nepafenac—Hypertension—Doxorubicin—pancreatic cancer	0.000165	0.00212	CcSEcCtD
Nepafenac—Skin disorder—Epirubicin—pancreatic cancer	0.000164	0.0021	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000162	0.00207	CcSEcCtD
Nepafenac—Dry mouth—Doxorubicin—pancreatic cancer	0.000159	0.00204	CcSEcCtD
Nepafenac—Vomiting—Docetaxel—pancreatic cancer	0.000159	0.00204	CcSEcCtD
Nepafenac—Headache—Docetaxel—pancreatic cancer	0.000157	0.00201	CcSEcCtD
Nepafenac—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000153	0.00196	CcSEcCtD
Nepafenac—Skin disorder—Doxorubicin—pancreatic cancer	0.000152	0.00194	CcSEcCtD
Nepafenac—Nausea—Docetaxel—pancreatic cancer	0.000149	0.00191	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000146	0.00187	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000135	0.00173	CcSEcCtD
Nepafenac—Hypersensitivity—Epirubicin—pancreatic cancer	0.000124	0.00159	CcSEcCtD
Nepafenac—Pruritus—Epirubicin—pancreatic cancer	0.000119	0.00153	CcSEcCtD
Nepafenac—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000115	0.00147	CcSEcCtD
Nepafenac—Dizziness—Epirubicin—pancreatic cancer	0.000112	0.00143	CcSEcCtD
Nepafenac—Pruritus—Doxorubicin—pancreatic cancer	0.000111	0.00142	CcSEcCtD
Nepafenac—Vomiting—Epirubicin—pancreatic cancer	0.000107	0.00138	CcSEcCtD
Nepafenac—Headache—Epirubicin—pancreatic cancer	0.000106	0.00136	CcSEcCtD
Nepafenac—Dizziness—Doxorubicin—pancreatic cancer	0.000103	0.00132	CcSEcCtD
Nepafenac—Nausea—Epirubicin—pancreatic cancer	0.0001	0.00128	CcSEcCtD
Nepafenac—Vomiting—Doxorubicin—pancreatic cancer	9.93e-05	0.00127	CcSEcCtD
Nepafenac—Headache—Doxorubicin—pancreatic cancer	9.79e-05	0.00125	CcSEcCtD
Nepafenac—Nausea—Doxorubicin—pancreatic cancer	9.28e-05	0.00119	CcSEcCtD
